Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
 
Sponsors and Collaborators
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
 
Contact
Vanderbilt-Ingram Cancer Center, Clinical Trials Information
1-800-811-8480
 
Investigator
Emily Chan, M.D., Ph.D
Vanderbilt-Ingram Cancer Center
 
ClinicalTrials.gov Identifier